Entrada Therapeutics
Price & Volume
Stats
See more52W Range | $4.93-$16.45 |
Market Cap | $263.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $5.7M |
Revenue Growth (YoY) | -95.7% |
Gross Profit (12 Mos) | -$135.8M |
Diluted EPS | -$4 |
News
See moreYahoo Finance • last month
TRDA Investors Have Opportunity to Join Entrada Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Yahoo Finance • last month
Entrada Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Yahoo Finance • 3 months ago
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
Yahoo Finance • 4 months ago
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Dipal Doshi |
CFO | Mr. Kory James Wentworth CPA |
Address | One Design Center Place, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 152 |